Signals Analytics Expands Rare Disease Data Coverage

February 21, 2020
Pharmaceutical Executive

Signals Analytics, analytics platform that leverages external data to uncover trends and predictive insights, announced the addition of 1,600 rare diseases, deepening its coverage of medical conditions and therapeutic areas.

The enhancement of rare diseases coverage offers pharmaceutical companies a comprehensive view of this hard-to-capture landscape with relevant insights that can allow opportunities for drug development, repurposing, and partnering.